iCAD Interview Guide

iCAD is a global leader dedicated to revolutionizing cancer detection through clinically proven AI-powered solutions that enhance the accuracy and reliability of early cancer detection, ultimately improving patient outcomes. Renowned for its ProFound Breast Health Suite, iCAD offers advanced AI-driven mammography analysis for breast cancer detection, density assessment, and risk evaluation. This innovative suite is FDA-cleared and licensed in multiple regions, including the EU and Canada, and is utilized by thousands of providers across over 50 countries, positively impacting millions of patients. iCAD is committed to advancing healthcare technology by developing AI solutions that integrate seamlessly into medical imaging and diagnostics, positioning itself at the forefront of the healthcare technology industry.